Evidence map›Paper›PMID 34574466›Full record

ArticleInternational journal of environmental research and public health2021

Genome of

Jaromír Astl, Richard Holy, Eva Maute, Jan Rotnágl, David Kalfeřt, Barbora Drnková, Temoore Younus, Emil Pavlík

Open access · goldAbstract read
In one paragraph

Article in International journal of environmental research and public health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Frontiers in medicine · 2024
    Article
  2. Review
  3. Low Prevalence of HSV-1 andDiagnostics (Basel, Switzerland) · 2023
    Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Jaromír AstlDepartment of Otorhinolaryngology and Maxilofacial Surgery, Military University Hospital Prague, 16902 Prague, Czech Republic.ORCID 0000-0002-8022-0200
Richard HolyDepartment of Otorhinolaryngology and Maxilofacial Surgery, Military University Hospital Prague, 16902 Prague, Czech Republic.ORCID 0000-0003-1112-6197
Eva MauteMaute HNO-Praxis, 85276 Pfaffenhofen an der Ilm, Germany.
Jan RotnáglDepartment of Otorhinolaryngology and Maxilofacial Surgery, Military University Hospital Prague, 16902 Prague, Czech Republic.ORCID 0000-0003-2692-0342
David KalfeřtDepartment of Otorhinolaryngology and Head and Neck Surgery, University Hospital Motol, 15006 Prague, Czech Republic.ORCID 0000-0003-4369-4113
Barbora DrnkováFirst Faculty of Medicine, Charles University, 12108 Prague, Czech Republic.
Temoore YounusThird Faculty of Medicine, Charles University, 10000 Prague, Czech Republic.ORCID 0000-0002-0306-3045
Emil PavlíkFirst Faculty of Medicine, Charles University, 12108 Prague, Czech Republic.
Charles University · CZUniversity Hospital in Motol · CZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveOropharyngeal/laryngeal carcinoma are common cancers of the upper aerodigestive system. Human papillomavirus (HPV) is described as the most frequent in the cancer of unknown primary. The presence of THE AIM OF STUDY: To analyze the incidence of HPV and HP in oropharyngeal/laryngeal cancer persons versus persons with chronic tonsillar inflammation and healthy persons.

methodsThe samples were taken in three groups: (1) tissue of oropharynx/larynx cancer (103 specimens); (2) tissue of palatine tonsils (85 specimens); and (3) healthy control group (50 specimens). We analyzed the presence of HP (PCR) and HPV genomic DNA (Sacace HPV High-Risk Screen Real-TM Quant) in the samples.

resultsHP was detected in 86 samples (83.5%) and high-risk HPV in 62 samples (60.2%). We found a very high incidence of HP. In the cancer group, HP was detected in 82.5% cases and HPV positivity in 57.8%. In total, 7.2% of the cancer patients were negative for HP and HPV together. In turn, 53.6% of the cancer patients were positive for HP and HPV together. Four cases (4.2%) were positive for HPV only. VacA positivity was detected in 82 (79.6%) of the cancer cases and VacA negativity in 21 (20.4%) if the cancer cases. The incidence of HP in chronic inflammation (

conclusionsWe suggest that the palatine tonsils are colonized by HP. In our study, HP was present in oropharyngeal cancer in more cases in comparison with HPV infection. The presence of VacA from HP can have an influence on the human epithelial and immune cells' regulation ways. Our results do not support idea that the CagA-positive HP is a primary carcinogen in oropharyngeal area.

Indexed as

AlphapapillomavirusHelicobacter InfectionsHelicobacter pyloriLaryngeal NeoplasmsPapillomavirus InfectionsHumansInflammationOropharynxPapillomaviridaeSerogroupchronic inflammationHelicobacter pylorihuman papilloma virusincidenceoropharynxsquamous cell carcinoma

Identifiers

PMID34574466
PMCPMC8470705
OpenAlexW3201372816

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.